Back
Janux Stock Jumps 12% on $850 Million Bristol Myers Cancer Deal
Back
Stock News
Themes
Janux Stock Jumps 12% on $850 Million Bristol Myers Cancer Deal
Janux Stock Jumps 12% on $850 Million Bristol Myers Cancer Deal
Edgen Stock
·
Jan 22 2026, 16:19
Share to
Share to
Copy link
BMY
-1.04%
JANX
+0.30%
source:
[1] Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
Recommend
Apple Stock Climbs as Investors Shun Big Tech's $650B AI Spending
Feb 18 2026, 00:32
Similarweb Swings to Profit, Beating Q4 Estimates
Feb 17 2026, 23:58
Hormel Sells Turkey Business, Reaffirms 2026 Guidance
Feb 17 2026, 23:57
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved
Edgen Stock·Jan 22 2026, 16:19Edgen Stock·Jan 22 2026, 16:19
Edgen Stock·Jan 22 2026, 16:19